SG10201408522UA - Enhanced stability phenylephrine liquid compositions - Google Patents

Enhanced stability phenylephrine liquid compositions

Info

Publication number
SG10201408522UA
SG10201408522UA SG10201408522UA SG10201408522UA SG10201408522UA SG 10201408522U A SG10201408522U A SG 10201408522UA SG 10201408522U A SG10201408522U A SG 10201408522UA SG 10201408522U A SG10201408522U A SG 10201408522UA SG 10201408522U A SG10201408522U A SG 10201408522UA
Authority
SG
Singapore
Prior art keywords
liquid compositions
enhanced stability
phenylephrine liquid
stability phenylephrine
enhanced
Prior art date
Application number
SG10201408522UA
Inventor
Bubnis William
Shield Stephanie
P Hoskovec Gayle
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38814551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201408522U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of SG10201408522UA publication Critical patent/SG10201408522UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG10201408522UA 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions SG10201408522UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/487,120 US20080014274A1 (en) 2006-07-14 2006-07-14 Enhanced stability phenylephrine liquid compositions

Publications (1)

Publication Number Publication Date
SG10201408522UA true SG10201408522UA (en) 2015-02-27

Family

ID=38814551

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011049558A SG173354A1 (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions
SG10201408522UA SG10201408522UA (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2011049558A SG173354A1 (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions

Country Status (26)

Country Link
US (1) US20080014274A1 (en)
EP (2) EP2351554B1 (en)
JP (1) JP2009543777A (en)
KR (2) KR20090040334A (en)
CN (2) CN101500539A (en)
AR (1) AR061985A1 (en)
AU (1) AU2007272961B2 (en)
BR (1) BRPI0714399B8 (en)
CA (1) CA2657611A1 (en)
CO (1) CO6180496A2 (en)
EC (1) ECSP099072A (en)
ES (2) ES2550036T3 (en)
HK (2) HK1128886A1 (en)
HU (2) HUE025694T2 (en)
IL (1) IL196447A (en)
MX (1) MX2009000530A (en)
NZ (1) NZ574148A (en)
PE (1) PE20081003A1 (en)
PL (2) PL2351554T3 (en)
PT (2) PT2040672E (en)
RU (1) RU2468787C2 (en)
SG (2) SG173354A1 (en)
TW (1) TW200812640A (en)
UY (1) UY30484A1 (en)
WO (1) WO2008008364A2 (en)
ZA (1) ZA200900315B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
EP2029105A1 (en) * 2006-06-01 2009-03-04 Schering Corporation Phenylphrine pulsed release formulations and pharmaceutical compositions
CN101505735A (en) * 2006-06-01 2009-08-12 先灵公司 Pharmaceutical compositions for sustained release of phenyephrine
PE20080151A1 (en) * 2006-06-01 2008-02-25 Schering Plough Healthcare PHARMACEUTICAL FORMULATIONS OF PHENYLPHRINE AND COMPOSITIONS FOR ITS ABSORPTION IN THE COLON
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
CN101848706A (en) * 2007-06-01 2010-09-29 先灵-普劳健康护理产品公司 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol
PE20091084A1 (en) * 2007-12-07 2009-07-23 Schering Plough Healthcare PHARMACEUTICAL FORMULATIONS OF PHENYLPHRINE AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
WO2011156822A2 (en) * 2010-06-11 2011-12-15 Gm Pharmaceuticals, Inc. Pharmaceutical compositions
EP2616064B1 (en) 2010-10-21 2019-08-07 Rtu Pharmaceuticals LLC Ready to use ketorolac formulations
FR2987268B1 (en) * 2012-02-28 2014-07-11 Ammtek LIQUID FORMULATIONS OF HYPOGLYCEMIC SULFAMIDES
PL2961377T3 (en) * 2013-02-28 2020-11-02 Pf Consumer Healthcare 1 Llc Enhanced stability of novel liquid compositions
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (en) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Liquid-filled dosage form to prevent immediate release abuse
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
JP5918894B1 (en) * 2015-05-21 2016-05-18 富士カプセル株式会社 Nalfurafine hydrochloride-containing capsule formulation
MX2017015202A (en) * 2015-05-29 2018-07-06 Codadose Incorporated Liquid formulations of celecoxib for oral administration.
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation
WO2018045170A1 (en) * 2016-09-01 2018-03-08 The Procter & Gamble Company Medication with improved taste and sensory experience
AU2017331369B2 (en) 2016-09-26 2019-11-21 The Procter & Gamble Company Extended relief dosage form
CN110115708A (en) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 Acetaminophen and C16H25NO2 are total to molten compound analgesic oral liquor
WO2019222100A1 (en) 2018-05-16 2019-11-21 Zumeta Perez Javier High concentration suspension formulation for cold and flu soft gel capsule medications
CN108434097A (en) * 2018-06-22 2018-08-24 南京济群医药科技股份有限公司 A kind of hydrochloric triprolidine oral solution of stabilization and preparation method thereof
CN109010341A (en) * 2018-10-29 2018-12-18 南京济群医药科技股份有限公司 A kind of compound oral solution and preparation method thereof containing dextromethorphan hydrobromide
EA202192792A1 (en) 2019-04-11 2022-01-11 Ар.Пи. ШЕРЕР ТЕКНОЛОДЖИЗ, ЭлЭлСи COMPOSITION FOR ORAL DELIVERY OF PROTEINS, PEPTIDES AND SMALL MOLECULES WITH WEAK PERMEABILITY
PL4081187T3 (en) 2019-12-23 2024-04-08 Nutra Essential Otc, S.L. Liquid composition comprising ibuprofen and phenylephrine
WO2021150747A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine hydrochloride compositions and containers
CN111773203A (en) * 2020-05-15 2020-10-16 北京博达绿洲医药科技研究有限公司 Preparation process of phenylephrine hydrochloride-containing composition
CN114533664B (en) * 2022-01-29 2023-03-31 江苏广承药业有限公司 Compound oral liquid preparation of dextromethorphan hydrobromide and guaiacol glyceryl ether

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
EP0901787B1 (en) * 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6287597B1 (en) 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
JP3450805B2 (en) * 2000-08-08 2003-09-29 わかもと製薬株式会社 Aqueous pharmaceutical composition
EP1411955A4 (en) 2001-07-31 2006-07-05 Wyeth Corp Sucralose formulations to mask unpleasant tastes
US6462094B1 (en) * 2001-08-22 2002-10-08 Medpointe Healthcare Inc. Decongestant/expectorant compositions
US6509492B1 (en) * 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US20040132827A1 (en) 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
JPWO2004037293A1 (en) * 2002-10-22 2006-02-23 大日本住友製薬株式会社 Stabilizing composition
US6979689B2 (en) 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
JP2004300138A (en) * 2003-03-18 2004-10-28 Takeda Chem Ind Ltd Stabilized oral solid preparation
US20050152967A1 (en) 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
DE10358213A1 (en) * 2003-12-12 2005-07-28 Clariant Gmbh Polyethylene glycol and its preparation
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070098785A1 (en) * 2005-11-02 2007-05-03 Tim Clarot Medicant delivery system and device
US20070160689A1 (en) * 2006-01-12 2007-07-12 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness

Also Published As

Publication number Publication date
KR20140088234A (en) 2014-07-09
EP2351554A1 (en) 2011-08-03
NZ574148A (en) 2012-07-27
KR20090040334A (en) 2009-04-23
TW200812640A (en) 2008-03-16
ECSP099072A (en) 2009-02-27
HK1205933A1 (en) 2015-12-31
CN101500539A (en) 2009-08-05
PL2351554T3 (en) 2016-01-29
WO2008008364A3 (en) 2008-05-22
EP2040672A2 (en) 2009-04-01
PE20081003A1 (en) 2008-07-13
CO6180496A2 (en) 2010-07-19
BRPI0714399B8 (en) 2021-05-25
AU2007272961B2 (en) 2011-07-28
ES2537761T3 (en) 2015-06-11
WO2008008364A2 (en) 2008-01-17
US20080014274A1 (en) 2008-01-17
HUE025694T2 (en) 2016-04-28
RU2468787C2 (en) 2012-12-10
CN104546671A (en) 2015-04-29
HK1128886A1 (en) 2009-11-13
IL196447A (en) 2015-06-30
BRPI0714399B1 (en) 2020-11-17
EP2351554B1 (en) 2015-09-09
ES2550036T3 (en) 2015-11-04
UY30484A1 (en) 2008-02-29
IL196447A0 (en) 2009-09-22
PL2040672T3 (en) 2015-07-31
HUE025790T2 (en) 2016-05-30
MX2009000530A (en) 2009-01-27
PT2040672E (en) 2015-07-02
JP2009543777A (en) 2009-12-10
AU2007272961A1 (en) 2008-01-17
AR061985A1 (en) 2008-08-10
BRPI0714399A2 (en) 2013-03-12
ZA200900315B (en) 2009-12-30
SG173354A1 (en) 2011-08-29
CA2657611A1 (en) 2008-01-17
EP2040672B1 (en) 2015-04-01
RU2009101295A (en) 2010-08-27
PT2351554E (en) 2015-11-02

Similar Documents

Publication Publication Date Title
IL196447A0 (en) Enhanced stability phenylephrine liquid compositions
HK1126975A1 (en) Pharmaceutical compositions with enhanced stability
GB2463582B (en) Functional fluid compositions
EP2040708A4 (en) Quercetin-containing compositions
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
GB0625322D0 (en) Pharmaceutical compositions
HK1138732A1 (en) Pharmaceutical compositions
GB0625069D0 (en) Compositions
GB0607085D0 (en) Novel compositions
GB0620279D0 (en) Compositions
GB0618657D0 (en) Compositions
EP1986849A4 (en) Washing-fast smoldering-suppressing compositions
GB0620918D0 (en) Compositions
GB0601899D0 (en) Compositions
GB0611033D0 (en) Compositions
GB0616336D0 (en) Fluid composition
GB0621950D0 (en) Compositions
GB0621751D0 (en) Compositions
GB0600411D0 (en) Compositions
GB0610477D0 (en) Compositions
GB0620204D0 (en) Compositions
GB0624424D0 (en) Compositions
GB0622456D0 (en) Compositions
GB0622092D0 (en) Compositions